Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACON NASDAQ:BGLC NYSE:SSY NASDAQ:VSEE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONAclarion$7.17+1.8%$7.30$6.20▼$3,499.51$4.16M1.3491,387 shs11,028 shsBGLCBioNexus Gene Lab$5.68-1.6%$5.28$2.01▼$15.60$10.21M5.341.15 million shs26,850 shsSSYSunLink Health Systems$1.12+16.6%$1.05$0.62▼$1.91$7.88M1.16145,367 shs243,934 shsVSEEVSee Health$0.60-22.1%$1.13$0.58▼$3.54$2.16MN/A383,916 shs598,590 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONAclarion-2.36%-4.94%-8.69%+10.00%-99.66%BGLCBioNexus Gene Lab+3.22%+0.87%+29.37%+32.64%+25.90%SSYSunLink Health Systems0.00%0.00%-9.76%+28.03%+34.51%VSEEVSee Health-8.85%-11.47%-42.52%-37.89%-48.99%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONAclarion2.3789 of 5 stars3.03.00.00.03.30.01.3BGLCBioNexus Gene Lab0.2298 of 5 stars0.02.00.00.03.30.00.0SSYSunLink Health SystemsN/AN/AN/AN/AN/AN/AN/AN/AVSEEVSee Health1.5631 of 5 stars2.04.00.00.01.90.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONAclarion 2.00Hold$11,758.50163,895.82% UpsideBGLCBioNexus Gene Lab 0.00N/AN/AN/ASSYSunLink Health Systems 0.00N/AN/AN/AVSEEVSee Health 4.00Strong Buy$5.00733.33% UpsideCurrent Analyst Ratings BreakdownLatest VSEE, BGLC, SSY, and ACON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025ACONAclarionAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeModerate Buy(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONAclarion$50K83.17N/AN/A$24.37 per share0.29BGLCBioNexus Gene Lab$9.55M1.07N/AN/A$4.19 per share1.36SSYSunLink Health Systems$31.09M0.25N/AN/A$2.27 per share0.49VSEEVSee Health$6.38M0.34N/AN/A($3.40) per share-0.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONAclarion-$6.99MN/A0.00N/AN/A-11,238.59%-83.63%-76.55%11/13/2025 (Estimated)BGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-30.70%-35.54%-29.08%N/ASSYSunLink Health Systems-$1.53M$0.244.66∞N/A5.55%-18.98%-14.79%N/AVSEEVSee Health-$4.41MN/A0.00∞N/AN/AN/AN/A9/22/2025 (Estimated)Latest VSEE, BGLC, SSY, and ACON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/18/2025Q2 2025BGLCBioNexus Gene LabN/A-$0.34N/A-$0.34N/A$2.26 million8/14/2025Q2 2025ACONAclarion-$2.26-$2.75-$0.49-$2.75$0.03 million$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONAclarionN/AN/AN/AN/AN/ABGLCBioNexus Gene LabN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/AVSEEVSee HealthN/AN/AN/AN/AN/ALatest VSEE, BGLC, SSY, and ACON DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/18/2025SSYSunLink Health Systemsspecial$0.107/31/20257/29/20257/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACONAclarionN/A23.8323.83BGLCBioNexus Gene LabN/A3.632.94SSYSunLink Health SystemsN/A3.913.50VSEEVSee HealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONAclarion7.52%BGLCBioNexus Gene Lab18.85%SSYSunLink Health Systems23.67%VSEEVSee Health1.01%Insider OwnershipCompanyInsider OwnershipACONAclarion0.77%BGLCBioNexus Gene Lab0.70%SSYSunLink Health Systems27.90%VSEEVSee Health6.59%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONAclarion7580,000578,000Not OptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableSSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableVSEEVSee HealthN/A3.60 million3.37 millionN/AVSEE, BGLC, SSY, and ACON HeadlinesRecent News About These CompaniesVSee Health receives expected additional notice of deficiency from Nasdaq related to delayed filing of Form 10-QAugust 22, 2025 | biznes.newseria.plBVSee Health Faces Nasdaq Delisting NoticeAugust 22, 2025 | tipranks.comVSee Health, Inc. (NASDAQ:VSEE) Sees Significant Decrease in Short InterestAugust 18, 2025 | americanbankingnews.comVSee Health Appeals NASDAQ Staff Delisting NoticeAugust 12, 2025 | accessnewswire.comAVSee Health stock plummets as Nasdaq delisting loomsAugust 11, 2025 | au.investing.comCORRECTING and REPLACING VSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 16, 2025 | businesswire.comVSee Health stock soars after launching AI doctor notes solutionJuly 14, 2025 | in.investing.comVSee Health Stock Jumps After Unveiling AI-Powered Doctor Notes ToolJuly 14, 2025 | msn.comVSee New AI Doctor Notes Reduces Documentation Time 93% – Transforming Virtual Emergency Care for Tele911July 14, 2025 | businesswire.comVSee Health ($VSEE): AI Telehealth Powerhouse Tapped for NIH Stroke Study as It Redefines the $787B Digital Healthcare MarketJune 26, 2025 | theglobeandmail.comVSee Health selected for NIH-funded stroke recovery telerehab trialJune 25, 2025 | investing.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial - Business WireJune 24, 2025 | businesswire.comVSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical TrialJune 23, 2025 | businesswire.comVSee Health faces Nasdaq compliance issue over late filingsJune 1, 2025 | investing.comVSee Health faces Nasdaq delisting over late filingJune 1, 2025 | uk.investing.comVSee Health, Inc. Receives Nasdaq Notice on Delayed Form 10-Q FilingMay 30, 2025 | businesswire.comVSee Health launches telehealth initiative in the PhilippinesMay 17, 2025 | investing.comVSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote PhilippinesMay 16, 2025 | businesswire.comVSee Health, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K FilingMay 12, 2025 | businesswire.comVSee Health Inc. Faces Nasdaq Delisting Over Late FilingMay 10, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVSEE, BGLC, SSY, and ACON Company DescriptionsAclarion NASDAQ:ACON$7.17 +0.13 (+1.85%) Closing price 03:59 PM EasternExtended Trading$7.00 -0.17 (-2.37%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.BioNexus Gene Lab NASDAQ:BGLC$5.68 -0.09 (-1.56%) Closing price 04:00 PM EasternExtended Trading$5.59 -0.09 (-1.65%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.SunLink Health Systems NYSE:SSY$1.12 +0.16 (+16.56%) Closing price 08/14/2025Extended Trading$1.12 0.00 (0.00%) As of 08/14/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.VSee Health NASDAQ:VSEE$0.60 -0.17 (-22.10%) Closing price 03:59 PM EasternExtended Trading$0.61 +0.01 (+1.33%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It 3 Reasons Gartner Could Be the Best Buy of Q3 NIO Just Got Its Second Upgrade of the Month, and It’s Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access